Use of Innovative Technologies in the Treatment of Osteoarthritis: Combined Action of High Frequency Neuromodulation and Intra-articular SARC Infiltration
Abstract:
Osteoarthritis (OA) remains a prevalent, debilitating condition that affects millions worldwide, primarily the elderly. Conventional treatments often fail to alleviate symptoms, leading to diminished quality of life for patients who are not candidates for joint replacement surgery. This study examines the efficacy of combining Pulsed High Frequency (PHF) neuromodulation therapy and Autologous Cytokine-Rich Serum (SARC) infiltration as an innovative, non-invasive treatment for OA. Eighteen patients with OA unresponsive to conventional therapies participated in this study, undergoing a single session of PHF neuromodulation and SARC infiltration. Results demonstrated a significant reduction in pain, as assessed by the Visual Analog Scale (VAS), and an improvement in joint mobility across various joints, including the knee, hip, and shoulder. These outcomes were sustained at a six-month follow-up, with approximately 80% of patients reporting a reduction in pain by at least 50%. Findings indicate that the PHF+SARC approach may offer a promising alternative for patients with refractory OA, providing long-term symptom relief and functional improvement with minimal intervention.
